Novartis AG is 145.6x more valuable than NEKTAR THERAPEUTICS by market capitalization ($292.08 B vs $2.01 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NKTR | NVS |
|---|---|---|
| Market cap | $2.01 B | $292.08 B |
| US-listed rank | #2110 | #47 |
| Revenue (latest FY) | $55.23M | - |
| Net income (latest FY) | -$164.00M | - |
| Net margin | -296.9% | - |
| SEC filings | 1,949 | 947 |
Novartis AG is 145.6x more valuable than NEKTAR THERAPEUTICS by market capitalization ($292.08 B vs $2.01 B).
Full pages: NEKTAR THERAPEUTICS and Novartis AG, or browse the full rankings.